International sport keeps trying to sell sex testing as if it were a clean laboratory solution to a messy policy fight. Swab the cheek, run the genetics, declare the category settled. It sounds neat. It sounds objective. It sounds like science rode in on a white horse and saved women’s sports from ambiguity. But that story falls apart the second you look at the biology, the history, and the policy context around these tests.
World Athletics now requires athletes seeking eligibility for the female category in world-ranking competitions to undergo a one-time SRY gene test, usually through a cheek swab or blood sample. If the test is negative for a Y chromosome marker, the athlete is eligible for the female category. If it is positive, the athlete is pushed into further review and may be ruled ineligible unless she fits a narrow exception, such as complete androgen insensitivity syndrome. Refusal to take the test means no eligibility for the female category in those competitions. By design, the policy applies only to athletes competing in the female category.
That last point matters. Men are not being lined up to prove they are men. There is no equivalent universal testing regime for the male category. The burden of proof lands on women, and specifically on women whose bodies, histories, or identities make sports officials uncomfortable. That is not a side effect. It is the structure of the rule itself. Because the test applies only to the female category, women absorb the privacy invasion, the stigma, the delays, and the cost.
And yes, this policy is inseparable from the campaign to keep trans women out of sports. World Athletics had already barred transgender women who experienced male puberty from the female category in 2023. The newer SRY testing rule adds another gatekeeping layer by treating the presence of Y-linked material as a decisive trigger for exclusion or further scrutiny. World Athletics itself says a positive result may occur in a transgender individual with male chromosomes regardless of past, present, or future hormone therapy. In other words, the science is being used to harden a policy choice that was already moving toward exclusion.
RELATED: New Sex Verification Tests in Sports Ignite Global Debate
The SRY Gene Is Not a Magic Truth Button
The science problem starts with the basic claim. World Athletics says the SRY gene is a reliable proxy for biological sex. But sex development in humans is not controlled by one neat switch that can be reduced to a yes or no answer on a swab. SRY is important, but it is not the whole story. Biological sex involves chromosomes, gonads, hormone production, hormone response, anatomy, and development over time. A test that asks only whether SRY-linked material is present does not tell you how a body developed, how that body responds to hormones, or whether the athlete has any meaningful performance advantage.
That critique is not coming only from activists. Andrew Sinclair, the scientist credited with discovering the SRY gene in humans, has publicly argued that using SRY as a stand-alone determinant of biological sex is overly simplistic and scientifically unsound. He notes that some people with XY chromosomes develop along typically female lines, while some people with XX chromosomes can develop testes without SRY. The point is not that biology is fake. The point is that biology is more complicated than sports regulators want to admit when a simple rule helps them police women’s participation.
This is where sports policy keeps cosplay-ing as certainty. A cheek swab can detect genetic material. It cannot, by itself, tell you whether an athlete went through a particular puberty pattern, whether her tissues respond to testosterone, whether she has a condition that blunts androgen effects, or whether any measurable sport-specific advantage exists in the event she actually competes in. When administrators turn that swab into a final answer, they are no longer following science. They are flattening science into bureaucracy.
Women Can Get Results That Do Not Reflect Athletic Advantage
One of the biggest problems with sex testing is that a “positive” result does not necessarily mean what the public thinks it means. World Athletics itself acknowledges that a positive SRY result can lead to further assessment for 46XY differences of sex development and that some affected individuals may have atypical reproductive or sexual anatomy and altered hormone production. That is already an admission that the first test is not enough. If the result needed no context, there would be no need for follow-up.
Consider complete androgen insensitivity syndrome, or CAIS. A person with CAIS can have XY chromosomes and a positive SRY result, yet her body cannot properly respond to androgens. In practical terms, that means the presence of Y-linked material does not automatically translate into the kind of androgen-driven athletic development sports officials claim to be screening for. Peer-reviewed literature has long described CAIS as a reason chromosomal testing fails as a proxy for actual sport-relevant physiology. Even the old Olympic screening programs found athletes with Y-linked markers who were allowed to compete because the simplistic test result did not equal unfair advantage.
That history is not ancient trivia. During Olympic sex verification programs in the 1990s, more than 2,000 women were screened in Barcelona and more than 3,000 in Atlanta. Among the positive findings in Atlanta, seven athletes had androgen insensitivity syndrome and one had 5-alpha-reductase deficiency. Notably, the literature reviewing those programs states that systematic gender testing never identified a man deliberately masquerading as a woman. What it did identify were women with intersex traits, many of whom were exposed to humiliation, suspicion, and public trauma.
That is the ugly little sequel nobody in power wants to pitch. These policies are marketed as fraud prevention, but the historic record shows they mostly catch women whose bodies do not fit a narrow administrative template. It is women, not cheating men, who end up investigated, medicalized, and publicly doubted.
False Readings Are Not Just Theoretical
Supporters of the new policy often repeat World Athletics’ claim that false positives and false negatives are extremely unlikely when labs use validated kits and proper methods. But “highly accurate” in a narrow laboratory sense is not the same thing as “socially or medically definitive” in the real world. Even outside sport, Y-chromosome and SRY-based testing can create sex-discrepant results in unusual but documented circumstances.
For example, peer-reviewed forensic and clinical literature shows that women who received stem cell or bone marrow transplants from male donors can show donor-derived male DNA in blood and buccal swabs. One study found donor-derived Y-linked material in buccal swabs and even hair follicles of female recipients after allogeneic stem cell transplantation, explicitly warning that analysis based on male-specific markers can lead to false identification of sex. Another case report described a woman whose medical testing showed high levels of Y chromosome material after a bone marrow transplant from a male donor, creating a sex discrepancy until clinicians traced the transplant history.
Are those cases common among elite athletes? No. But that is not the point. The point is that the test is not the pure, context-free truth machine it is being sold as. A policy that can affect careers, reputations, eligibility, and mental health should not be built on public messaging that treats rare-but-real edge cases as too inconvenient to mention. Science worth trusting is honest about limits. Propaganda pretends limits do not exist.
There is also a broader category of “false reading” that matters even when the lab result is technically correct. If the swab detects SRY in an athlete with CAIS or another variation of sex development, the result may be analytically accurate while still being a poor indicator of athletic capacity, hormone response, or event-specific competitive edge. That is the core scientific criticism. A result can be genetically correct and still biologically misleading when used as a blunt eligibility weapon.
The Harm Does Not Stop at the Lab
These tests do not affect women equally. They create a hierarchy of suspicion. Women who are gender nonconforming, intersex, trans, from the Global South, Black, brown, visibly muscular, or simply “too dominant” in the eyes of commentators are historically more likely to face scrutiny. Even when a rule is written as universal, enforcement tends to land hardest on the women whose bodies already attract public policing. That pattern has defined sex testing in sport for decades.
There is also the privacy issue. A positive test can force an athlete into follow-up medical assessments that may reveal deeply personal information about chromosomes, gonads, fertility, anatomy, or hormone function. World Athletics says results should be held by the athlete and handled confidentially, but elite sport is not exactly famous for airtight privacy once an athlete’s eligibility becomes news. A supposedly simple eligibility screen can quickly become a pipeline into unwanted medical exposure.
Then there is the psychological damage. The older literature on Olympic verification is blunt: these programs caused emotional trauma and social stigmatization for many female athletes with intersex traits and lacked strong scientific merit as blanket screening tools. That is not a minor bug in the system. That is the system. The very act of forcing women to prove their womanhood through testing creates shame, suspicion, and public spectacle around bodies that were never the problem to begin with.
What About Competitive Fairness?
Fairness matters. Nobody serious is arguing otherwise. The problem is that sports bodies keep pretending fairness can be protected through simplistic biological sorting rules that ignore the actual complexity of performance. Athletic success is shaped by training, access, coaching, nutrition, genetics, event specialization, body size, reaction time, psychology, and money. Sport has never required equal bodies. It has required administratively workable categories. The question is whether those categories are built on evidence and applied with proportionality.
Even the evidence base on trans women and performance is more limited than culture-war pundits pretend. A recent pooled analysis reported that while transgender women may retain some body composition differences after hormone therapy, available evidence found comparable physical fitness measures to cisgender women in some areas, while also noting important limitations, especially the lack of elite-athlete data. That does not settle every sports-policy question. But it does undercut the lazy political claim that trans women are self-evidently, universally, permanently advantaged in every context and therefore require ever more extreme exclusion tools.
The International Olympic Committee’s 2021 framework took a more cautious approach, warning against excluding athletes based solely on an unverified, alleged, or perceived unfair advantage and opposing medically unnecessary procedures imposed as a condition of participation. Sports bodies are free to set sport-specific rules, but the IOC framework reflected a basic truth: if you are going to limit participation, you need evidence tied to the actual sport and actual performance question, not just vibes plus chromosome panic.
This Is About More Than One Test
The larger pattern is impossible to miss. First came panic about trans girls in school sports. Then bans on trans women after male puberty. Then hormone thresholds. Then “open category” proposals nobody funds or builds properly. Now genetic pre-clearance for women’s eligibility. The language is always fairness. The direction of travel is always exclusion.
That is why it is not enough to argue only about lab accuracy. The bigger issue is how the test functions politically. It tells the public that women’s sports are under siege and that the threat can be located in women’s DNA. It conditions audiences to see any woman who looks unusual, runs too fast, or does not fit feminine norms as potentially fraudulent. And it folds intersex women and trans women into the same apparatus of suspicion, even when their bodies and situations are medically distinct.
Science can inform sports policy. It can help explain physiology, puberty, hormones, and performance. But science is being misused when a single gene marker is elevated into a moral border wall around womanhood. That is not precision. That is politics in a lab coat.
The Bottom Line
Sex testing in women’s sports is not a neutral housekeeping measure. It places the burden on women alone, especially women whose bodies already draw suspicion. It relies on an overly simplistic biological shortcut. It can produce results that do not map cleanly onto athletic advantage. In rare but real cases, it can even create sex-discrepant readings because human biology is messy and medicine is complicated. And in the current political climate, it functions as part of a broader project to lock trans women out of sport while making all women prove they belong there.
If sports organizations truly cared about women, they would protect women’s privacy, dignity, and safety with the same energy they bring to policing chromosomes. Instead, they keep handing us the same old script with updated branding: test the women, trust the panic, call it fairness. It was bad science before. It is bad science now. And women are still the ones paying for it.
